Search Form
First, enter a politician or zip code
Now, choose a category
 

Bernie Sanders' Public Statements on Issue: Drugs

Office: U.S. Senate (VT) - Jr, Independent
Date Title
July 14, 2016 Letter to Mitch McConnell, Majority Leader of the United States Senate - As Congress Clears Comprehensive Addiction and Recovery Bill, Reed Calls for Emergency Funding for Opioid Epidemic
July 13, 2016 Letter to The Honorable Mitch McConnell. Majority Leader, United States Senate - Commit to Passing Real, Immediate Funding to Fight Opioid and Heroin Epidemic and Actually Carry Out Programs Authorized in CARA Bill
July 13, 2016 Sanders Statement on Opioid Legislation
July 7, 2016 Letter to the Honorable Robert M. Califf, Commissioner of the Food and Drug Administration - Condemning AstraZeneca for Putting Profits Over People
June 1, 2016 Letter to The Honorable Sylvia M. Burwell, Secretary of Health and Human Services - Urging DHHS to Increase Access to Opioid Addiction Treatment
May 31, 2016 Sanders, Nurses, Doctors Call for Medicare-for-All, Senator Backs California Ballot Initiative on Prescription Drug Prices
May 25, 2016 Sanders Backs California Ballot Initiative to Rein in Drug Prices at Meeting with HIV/AIDS Advocates
March 28, 2016 Letter to the Honorable Sylvia M. Burwell, Secretary of Health and Human Services and Francis Collins, Director of National Institutes of Health - Act Now on Drug Affordability
March 13, 2016 Full Rush Transcript Senator Bernie Sanders //CNN TV One Democratic Presidential Town Hall
March 11, 2016 Sanders Announces $1.2 Million in Health Center Funds for Substance Abuse Treatment in Vermont
Jan. 26, 2016 Sanders Places Hold on FDA Nominee
Jan. 16, 2016 The Fourth Democratic Debate
Dec. 23, 2015 Following Sanders Investigation, Vermont Secures Discount on Life-Saving Drug
Dec. 19, 2015 Third Democratic Debate
Nov. 29, 2015 New Hampshire Democratic Party Jefferson-Jackson Dinner
Nov. 14, 2015 Democratic Debate Transcript: Clinton, Sanders, O'Malley in Iowa
Oct. 29, 2015 Letter to Sylvia M. Burwell, Secretary of the Department of Health and Human Services - Overdose Prevention
Oct. 29, 2015 Trade Act of 2015
July 29, 2015 Letter to Stephanie Rawlings-Blake, President of the United States Conference of Mayors, and Sallie Clark, President of the National Association of Counties - Naloxone Cost and Access
July 13, 2015 Letter to John Kickenlooper, Governor of Colorado, Nancy Wyman, Lieutenant Governor of Connecticut, and Marty Jackley, Attorney General of South Dakota - Reduction in the Cost of Naloxone
March 2, 2015 Letter to Jack Zhang, CEO of Amphastar Pharmaceuticals, Incorporated - Price Increases for Drug that Police Use to Treat Overdoses
Jan. 1, 2015 Issue Position: Racial Justice
Dec. 23, 2014 Letter to Sylvia Mathews Burwell, Secretary of the Department of Health and Human Services - Opioid Abuse
Dec. 22, 2014 Letter to Sylvia Mathews Burwell, Secretary of U.S. Department of Health and Human Services - More Needs to be Done to Address Heroin Epidemic
Nov. 20, 2014 Drugmakers Mum on Huge Price Hikes
Nov. 20, 2014 US News - Price Spikes for Once-Cheap Generic Drugs Draw Scrutiny from Senate Lawmakers
Nov. 20, 2014 Sanders and Cummings Introduce Legislation to Require Drug Company Rebates for Generic Drugs
Nov. 11, 2014 Congressional Panel to Probe Generic Drug Price Hikes
Oct. 9, 2014 Sanders Investigating Drug Prices
Oct. 2, 2014 Letter to Brenton Saunders, CEO and President of Actavis PLC - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Umang Vohra, Executive Vice President of Dr. Reddy's Laboratories LTD - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Erez Vigodman, President and CEO of Teva Pharmaceutical Industries - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Joseph Renner, CEO of Zydus Pharmaceuticals - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Cummings and Sanders Investigate Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Brian Lortie, President at Endo International PLC - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Jeffrey Aronin, Chairman and CEO of Marathon Pharmaceuticals - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Paul Campanelli, CEO of Par Pharmaceutical Companies - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Dilip Shanghvi, Managing Director of Sun Pharmaceutical Industries - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Heather Bresch, CEO of Mylan - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Jeffrey Glazer, President and CEO of Heritage Pharmaceuticals - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Carole Ben-Maimon, President of Global Pharmaceuticals - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Michael Raya, President and CEO of West-Ward Pharmaceutical Corporation - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Jeffrey Watson, President of Apotex Corporation - Investigating Staggering Price Increases for Generic Drugs
Oct. 2, 2014 Letter to Arthur Bedrosian, President and CEO of Lannett Company - Investigating Staggering Price Increases for Generic Drugs
Sept. 12, 2014 Leahy, Sanders, Welch: Grant Will Help Expand the Lund Center's Help to Pregnant and Postpartum Women in Conquering Substance Abuse
March 13, 2012 Letter to The Honorable Margaret Hamburg, Commissioner of Food and Drug Administration
Feb. 2, 2012 Sanders Backs Bill to Relieve Prescription Drug Shortages
Oct. 12, 2011 United States-Korea Free Trade Agreement Implementation Act--Continued
June 27, 2011 The Budget
June 16, 2011 Letter to The Honorable Margaret Hamburg, Commissioner, Food and Drug Administration
Skip to top
Back to top